Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythroid-potentiating activity: characterization and target cells

C E Gauwerky, A J Lusis, D W Golde

    Experimental Hematology
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes.

    Diabetes & metabolism·2020
    Same author

    Heparin-binding EGF-like growth factor (HB-EGF) antisense oligonucleotide protected against hyperlipidemia-associated atherosclerosis.

    Nutrition, metabolism, and cardiovascular diseases : NMCD·2019
    Same author

    Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.

    Journal of thrombosis and haemostasis : JTH·2018
    Same author

    Heritability of periodontal bone loss in mice.

    Journal of periodontal research·2015
    Same author

    Zbtb16 has a role in brown adipocyte bioenergetics.

    Nutrition & diabetes·2013
    Same author

    The mouse model for atherosclerosis.

    Trends in cardiovascular medicine·2011

    Researchers identified a novel human cell line producing factors that stimulate hematopoietic cell growth, including a potent erythroid-potentiating activity (EPA) crucial for red blood cell development.

    Area of Science:

    • Hematology
    • Cell Biology
    • Molecular Biology

    Background:

    • Hematopoietic stem cells give rise to all blood cell types.
    • Erythropoiesis, the production of red blood cells, is a tightly regulated process.
    • Growth factors play a critical role in regulating hematopoiesis.

    Purpose of the Study:

    • To establish a human cell line producing hematopoietic growth factors.
    • To characterize the erythroid-potentiating activity (EPA) produced by this cell line.
    • To investigate the potential of erythroleukemia cell lines as models for studying EPA action.

    Main Methods:

    • Establishment and characterization of a human T-lymphoblast cell line (Mo).
    • Partial purification and biochemical characterization of erythroid-potentiating activity (EPA).

    Related Experiment Videos

  • Assay of EPA activity using normal human erythroid progenitors and erythroleukemia cell lines (K-562, Friend erythroleukemia).

    • Main Results:

    • The Mo cell line produces factors stimulating hematopoietic cell proliferation, including colony-stimulating factor and EPA.
    • Partially purified EPA is an acidic glycoprotein (45,000 daltons) with significant heat stability.
    • EPA activity is physically separable from colony-stimulating factor and stimulates erythroleukemia cell proliferation, showing some species restriction.

    Conclusions:

    • The Mo cell line is a valuable source of hematopoietic growth factors, particularly EPA.
    • Partially purified EPA demonstrates biological activity on erythroid progenitors and erythroleukemia cells.
    • Further purification and structural analysis of EPA are necessary to elucidate its mechanism of action and relationship to other erythropoietic factors.